Clinicopathological parameters such as young age, never smoking, well-differentiated tumor, and good performance showed a trend toward better response to treatment, but were not statistically significant.
← all excerpts
NANOG as an adverse predictive marker in advanced non-small cell lung cancer treated with platinum-based chemotherapy.
1
—
—